Exposing people to a potentially fatal disease could hasten understanding of COVID-19 and development of new vaccines and treatments. But the risks of such studies raise serious ethical questions.
The Code Breaker profiles Jennifer Doudna, a Nobel Prize-winning biochemist key to the development of CRISPR, and examines the technology's exciting possibilities and need for oversight.
The 85-year-old Tibetan spiritual leader scrapped plans to receive the injection at home, opting instead to travel to a clinic. "More people should have courage to take this injection," he said.
At work every day, Agnes Boisvert attends to ICU patients "gasping for air" and dying from COVID-19. But communicating that harsh reality to her skeptical community has been a challenge.
As the new Johnson & Johnson COVID-19 vaccine rolls out, the health care community is trying to ward off misconceptions about it. The vaccine's one-shot feature may be what wins many over.
As the pace of vaccination picks up, so do reports of spoiled doses. In Tennessee, close to 5,000 doses have been lost, prompting more oversight from state and federal officials.
The third COVID-19 vaccine authorized for use in the U.S. requires one shot instead of two, and works a slightly different way from the others. Here's what we know about its safety and effectiveness.
NPR's Mary Louise Kelly talks with Dr. Janet Woodcock, acting commissioner of the Food and Drug Administration, about coronavirus tests and the future of COVID-19 vaccines.
Many U.S. doctors have received their COVID-19 vaccines, but nearly a third are foreign-born with family in countries facing no access to it — a disparity that troubles many as they fight the virus.